Pediatric Neurology
Volume 25, Issue 3 , Pages 199-207, September 2001

Antiepileptic drugs: affective use in autism spectrum disorders

  • Adriana Di Martino, MD

      Affiliations

    • Department of Neuroscience; Child Neurology and Psychiatry; University of Cagliari; Cagliari, Italy
  • ,
  • Roberto F Tuchman, MD

      Affiliations

    • Department of Neurology; Dan Marino Center; Miami Children’s Hospital; Weston, Florida, USA
    • Corresponding Author InformationCommunications should be addressed to: Dr. Tuchman; Director; Dan Marino Center; Department of Neurology; Miami Children’s Hospital; 2900 South Commerce Parkway; Weston, FL 33331

Received 10 November 2000; accepted 5 March 2001.

Abstract 

Antiepileptic drugs are widely administered to individuals with autistic spectrum disorders. There are several reasons for the use of antiepileptic drugs in autistic spectrum disorders, including the high incidence of epilepsy in these individuals, the anecdotal reports suggesting an improvement of communication and behavior in autistic subjects with epileptic discharges, and the increased awareness that some disruptive behaviors may be manifestations of an associated affective disorder. In this study, data on the current use of antiepileptic drugs in the treatment of autism, and on the association of affective disorders with epilepsy and autism, are reviewed. The evidence supporting the hypothesis that there may be a subgroup of autistic children with epilepsy and affective disorders that preferentially respond to antiepileptic drugs is still very preliminary, and further investigations with double-blind controlled studies are needed. Although the role of antiepileptic drugs at the present time is not established, there is evidence that autism, epilepsy, and affective disorders commonly co-occur, and that they may share a common neurochemical substrate, which is the common target of the psychotropic mechanism of action of different antiepileptic drugs.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-8994(01)00276-4

Pediatric Neurology
Volume 25, Issue 3 , Pages 199-207, September 2001